Stock Mumak

Stock Profile

SpaceX

SpaceX impresses with strong growth and Starlink. But the high valuation and ambitious expectations increase the risk.

Stock Snapshot

SpaceX-Logo
Table HeaderTable Header
CompanySpace Exploration Technologies Corp. (SpaceX)
SectorDefense & Aerospace
ThemeSpace, Satellites & Communications
Business ModelDevelopment of space systems and operation of satellite-based communications services
ISINUS84615Q1031
Market Capitalizationapprox. $2.33 trillion (as of October 2026)
UMBRELLA StatusActive

UMBRELLA History

The key milestones of SpaceX within the UMBRELLA Strategy.

October 1, 2026
↑
Position Increase

Core Position Further Strengthened

October 5, 2026
↑
Position Increase

SpaceX Becomes the Largest Position

October 15, 2026
↓
Reduction

SpaceX weighting reduced

October 30, 2026
↓
Reduction

SpaceX Position Further Reduced

November 5, 2026
↓
Reduction

SpaceX Position Further Reduced

Latest Developments

↓
Reduction
November 5, 2026

SpaceX Position Further Reduced

The UMBRELLA Strategy further reduced its position in SpaceX following significant share price declines. The adjustment reflected the strategy's active risk management approach and aimed to limit further downside exposure.

↓
Reduction
October 30, 2026

SpaceX Position Further Reduced

The SpaceX position was reduced again on October 30 as part of ongoing portfolio adjustments. This further lowered the strategy's exposure to the space and satellite sector.

↓
Reduction
October 15, 2026

SpaceX weighting reduced

The SpaceX position was partially reduced as part of the portfolio adjustment. With a weighting of approximately 14.5%, SpaceX remained one of the largest holdings in the UMBRELLA Strategy.

↑
Position Increase
October 5, 2026

SpaceX Becomes the Largest Position

The weighting was increased from around 13.9% to approximately 18.6%. This represents an increase of around 4.7 percentage points, or approximately 34% compared with the previous position size. Capital released from reductions in Bayer and other positions was selectively reallocated to SpaceX.

↑
Position Increase
October 1, 2026

Core Position Further Strengthened

The weighting was increased from around 12.5% to 13.0%.

↑
Position Increase
September 1, 2026

Weighting Further Increased

As part of the portfolio realignment, the SpaceX position was increased again. By early September, the position already accounted for around 12% of the portfolio.

↑
Position Increase
August 10, 2026

SpaceX Position Further Increased

The existing position was expanded through several partial purchases. SpaceX increasingly developed into a strategic core position within the UMBRELLA Strategy.

Price Performance (12 Months)

Latest Portfolio Updates

Weekly Update

Weekly Market Overview – November 2–November 8, 2026

A massive sell-off in US markets, exceptional quarterly results in healthcare, and extensive risk reductions: the UMBRELLA strategy responds to
Company Update

Revolution Medicines – Q3 2026 Earnings Update

RASONQUE launch brings first revenues, research expenses remain high.
Company Update

Rheinmetall – Q3 2026 Earnings Update

Strong Q3 2026, stock under pressure after guidance cut.
Strategy in Action

Bayer – Position further expanded

The UMBRELLA strategy continues to expand its Bayer position. Positive price momentum, progress in the pharmaceutical business, and an improved
All Portfolio Updates

Termine & Ereignisse

DatumEreignisDetails
19. Nov. 2026 Quartalszahlen Q3 2026 Umsatz, Margen und Ausblick
10. Dez. 2026 Investorentag Strategie und Unternehmensentwicklung
20. Aug. 2026 Quartalszahlen Q2 2026 Ergebnisse und Geschäftsverlauf
15. Mai 2026 Quartalszahlen Q1 2026 Umsatz und Ergebnisentwicklung